Table 1.
Antibody | Antigen(s) | Method | KD (M) | kon (M−1 s−1)(b) | koff (s−1)(b) | Ref |
---|---|---|---|---|---|---|
O1(a) | 2 % GalC in SLB |
SPR | (2.37±0.56)×10−9 | (6.98±4.92)×105 | (1.10±0.51)×10−3 | This study |
O4(a) | 2 % Sulf in SLB |
SPR | (2.19±0.61)×10−9 | (2.65±1.71)×105 | (3.73±1.15)×10−4 | This study |
F5-2 | Actin Myosin Tubulin |
SPR | 4.03 × 10−8 2.74 × 10−8 6.80 × 10−8 |
1.85 × 104 2.84 × 104 1.67 × 104 |
7.46 × 10−4 7.78 × 10−4 1.14 × 10−3 |
49 |
2E4 | ssDNA β-galactosidase Insulin |
ELISA | 4 × 10−8 7 × 10−7 1 × 10−5 |
N.D. | N.D. | 50 |
274.RA.F11 | IgG Fc frag. | ELISA | 4 × 10−5 | N.D. | N.D. | 51 |
274.RA.F5 | IgG Fc frag. | ELISA | 3 × 10−7 | N.D. | N.D. | 51 |
Ab 50 | IgG Fc frag. ssDNA Insulin Tetanus toxoid |
ELISA | 1 × 10−5 5.6 × 10−7 1 × 10−4 6.4 × 10−6 |
N.D. | N.D. | 52 |
Ab 52 | IgG Fc frag. ssDNA Insulin Tetanus toxoid |
ELISA | 3 × 10−5 1 × 10−6 1 × 10−4 2.5 × 10−6 |
N.D. | N.D. | 52 |
KD, kon and koff values reported as mean ± s.e.m.
N.D. = not determined.